Frank Grazzini, II

Executive Officer at Pacegenix

Capital raised by Pacegenix

$22.5M+$22.5M latest round

1 Form D filing · first filed Mar 2026 · Cambridge, MA

Career

1 company on file · founded 2024

PacegenixBiotech · Cambridge, MAsince 2024

Executive Officer

Listed on Pacegenix's Form D filings

via EDGAR · Form D for Pacegenix1

DateCompanyFormAmountRole on filing

Mar 11, 2026PacegenixForm D+$22.5M—

Form DMar 11, 2026 · Pacegenix+$22.5Mnot a signer

Last filing Mar 11, 2026

Frank Grazzini, II is on file as Executive Officer at Pacegenix in Cambridge, MA. Pacegenix has 1 Form D filing on record, $22.5M raised in total.

Pacegenix · 1

Pacegenix · 1

PACE-101Cardiovascular therapeutic (drug candidate)

A rhythm-control drug candidate targeting atrial fibrillation in patients with hypertrophic cardiomyopathy (AF-HCM).